Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Retina ; 32(7): 1328-36, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22450514

RESUMO

PURPOSE: To determine whether a natural dye solution based on lutein and zeaxanthin alone or combined with Brilliant Blue stains and facilitates peeling of intraocular membranes in human eyes. METHODS: In this study of 60 cadaveric eyes, open-sky vitrectomy including posterior hyaloid detachment was performed. Different lutein and zeaxanthin concentrations (0.01-20%) were tested alone or combined with different Brilliant Blue concentrations (0.0125-0.025%) in the corneal endothelium, corneal epithelium, anterior and posterior capsule, vitreous cavity through the macula including the posterior hyaloid, and internal limiting membrane. The various dye solutions were in contact with the intraocular membranes for <1 minute and then were removed by mechanical aspiration or membrane peeling initiated and completed with intraocular forceps. The specimens were examined by light and electron transmission microscopy. RESULTS: Contact between lutein and zeaxanthin and the retinal, lens, and vitreous surface resulted in orange and greenish staining of the intraocular membranes, which facilitated surgical steps in all eyes. Lutein and zeaxanthin alone was useful for vitreous identification and lutein and zeaxanthin combined with Brilliant Blue had strong affinity for internal limiting membrane and anterior capsule. Light microscopy confirmed internal limiting membrane removal in all eyes tested. No dye solutions remained in the eyes after the membrane removal. CONCLUSION: A natural dye solution based on lutein and zeaxanthin alone or combined with Brilliant Blue efficiently stained the anterior capsule, vitreous, and internal limiting membrane in human cadaveric eyes and may be a useful tool for vitreoretinal or cataract surgery.


Assuntos
Cápsula Anterior do Cristalino/anatomia & histologia , Membrana Basal/anatomia & histologia , Benzenossulfonatos , Extração de Catarata , Corantes , Luteína , Cirurgia Vitreorretiniana , Corpo Vítreo/anatomia & histologia , Xantofilas , Cápsula Anterior do Cristalino/ultraestrutura , Membrana Basal/ultraestrutura , Benzenossulfonatos/química , Benzenossulfonatos/toxicidade , Corantes/química , Corantes/toxicidade , Combinação de Medicamentos , Humanos , Período Intraoperatório , Luteína/química , Luteína/toxicidade , Coloração e Rotulagem/métodos , Corpo Vítreo/ultraestrutura , Xantofilas/química , Xantofilas/toxicidade , Zeaxantinas
2.
Eur J Nutr ; 49(8): 447-57, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20361333

RESUMO

PURPOSE: The aim of the present study was to evaluate the in vitro effect of carotenoid astaxanthin (ASTA) on the phagocytic and microbicidal capacities, cytokine release, and reactive oxygen species production in human neutrophils. METHODS: The following parameters were evaluated: cytotoxic effect of ASTA on human neutrophils viability, phagocytic and microbicidal capacities of neutrophils by using Candida albicans assay, intracellular calcium mobilization (Fura 2-AM fluorescent probe), superoxide anion (lucigenin and DHE probes), hydrogen peroxide (H2O2, phenol red), and nitric oxide (NO·) (Griess reagent) production, activities of antioxidant enzymes (total/Mn-SOD, CAT, GPx, and GR), oxidative damages in biomolecules (TBARS assay and carbonyl groups), and cytokine (IL-6 and TNF-alpha) release. RESULTS: Astaxanthin significantly improves neutrophil phagocytic and microbicidal capacity, and increases the intracellular calcium concentration and NO· production. Both functional parameters were accompanied by a decrease in superoxide anion and hydrogen peroxide and IL-6 and TNF-α production. Oxidative damages in lipids and proteins were significantly decreased after ASTA-treatment. CONCLUSIONS: Taken together our results are supportive to a beneficial effect of astaxanthin-treatment on human neutrophils function as demonstrated by increased phagocytic and fungicide capacity as well as by the reduced superoxide anion and hydrogen peroxide production, however, without affecting neutrophils capacity to kill C. albicans. This process appears to be mediated by calcium released from intracellular storages as well as nitric oxide production.


Assuntos
Antioxidantes/farmacologia , Neutrófilos/efeitos dos fármacos , Fagocitose/efeitos dos fármacos , Antioxidantes/toxicidade , Cálcio/metabolismo , Candida albicans/efeitos dos fármacos , Catalase/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Citocinas/metabolismo , Dimetil Sulfóxido/farmacologia , Dimetil Sulfóxido/toxicidade , Glutationa Peroxidase/metabolismo , Glutationa Redutase/metabolismo , Humanos , Sistema Imunitário/efeitos dos fármacos , Neutrófilos/metabolismo , Neutrófilos/fisiologia , Óxidos de Nitrogênio/metabolismo , Estresse Oxidativo , Espécies Reativas de Oxigênio/metabolismo , Superóxido Dismutase/metabolismo , Xantofilas/farmacologia , Xantofilas/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA